Health Condition 1: L409- Psoriasis, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
All India Institute of Medical Sciences Bathinda Punjab
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients above 18 years of age 2.Patients of psoriasis who have not taken any form of treatment in the last 1 month. 3.Patients who are willing to sign the written consent form before participating in the study
Exclusion criteria
Exclusion criteria: 1.Patient having history of chronic hepatic and renal disease, diabetes mellitus, cardiovascular diseases and malignancies. 2.Those with history of chronic smoking, drug abuse and having morbid obesity (BMI above 30kg/square metre). 3.Patients who are taking lipid-lowering agents. 4.Patients having chronic inflammatory disease, immunological disorders with associated endothelial dysfunction. 5.Pregnant and lactating female.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To correlate the atherogenic indices with cardiovascular risk in psoriasis patientsTimepoint: Outcome will be assessed at the time of patient visit | — |
Secondary
| Measure | Time frame |
|---|---|
| To study any correlation between Atherogenic Indices & CIMT with disease severity Timepoint: Outcome will be assessed at the time of patient visit | — |
Countries
India
Contacts
Public ContactDr. Kavita Poonia
All India Institute of Medical Sciences
Outcome results
None listed